Monthly FDA Guidance and Regulatory News Review - September 2026
This September 2026 regulatory update focuses on FDA’s new guidance on neonatal parenteral...
This September 2026 regulatory update focuses on FDA’s new guidance on neonatal parenteral...
This August 2026 regulatory update focuses on the FDA finalizing three guidances addressing formal...
This July 2026 regulatory update focuses on the FDA finalizing six guidances that addresses...
This June 2026 regulatory update focuses on advancing innovative drug development through updated...
This May 2026 regulatory update highlights multiple guidances issued by the FDA across cell and...
This April 2026 regulatory update highlights new policies on biomarker validation, expanded access...
March 2026 regulatory updates underscore newly published final and draft guidances focused on...
In February 2026, FDA activity included new draft guidances, regulatory initiatives (e.g., PreCheck...
January 2026 regulatory updates underscored evolving AI-focused policies, ongoing scrutiny of...
December 2025 capped the year with a robust slate of FDA activity, including multiple final and...